Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Neurocrine Biosciences Total Assets 2010-2024 | NBIX

Neurocrine Biosciences total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Neurocrine Biosciences total assets for the quarter ending December 31, 2024 were $3.719B, a 14.37% increase year-over-year.
  • Neurocrine Biosciences total assets for 2024 were $3.719B, a 14.37% increase from 2023.
  • Neurocrine Biosciences total assets for 2023 were $3.251B, a 37.27% increase from 2022.
  • Neurocrine Biosciences total assets for 2022 were $2.369B, a 14.29% increase from 2021.
  
Neurocrine Biosciences Annual Total Assets
(Millions of US $)
2024 $3,719
2023 $3,251
2022 $2,369
2021 $2,073
2020 $1,735
2019 $1,306
2018 $993
2017 $818
2016 $365
2015 $475
2014 $243
2013 $155
2012 $196
2011 $138
2010 $144
2009 $71
Neurocrine Biosciences Quarterly Total Assets
(Millions of US $)
2024-12-31 $3,719
2024-09-30 $3,535
2024-06-30 $3,305
2024-03-31 $3,472
2023-12-31 $3,251
2023-09-30 $2,848
2023-06-30 $2,613
2023-03-31 $2,360
2022-12-31 $2,369
2022-09-30 $2,143
2022-06-30 $2,006
2022-03-31 $2,145
2021-12-31 $2,073
2021-09-30 $2,017
2021-06-30 $1,956
2021-03-31 $1,846
2020-12-31 $1,735
2020-09-30 $1,503
2020-06-30 $1,516
2020-03-31 $1,362
2019-12-31 $1,306
2019-09-30 $1,180
2019-06-30 $1,067
2019-03-31 $958
2018-12-31 $993
2018-09-30 $934
2018-06-30 $841
2018-03-31 $806
2017-12-31 $818
2017-09-30 $772
2017-06-30 $754
2017-03-31 $289
2016-12-31 $365
2016-09-30 $399
2016-06-30 $430
2016-03-31 $459
2015-12-31 $475
2015-09-30 $492
2015-06-30 $511
2015-03-31 $528
2014-12-31 $243
2014-09-30 $258
2014-06-30 $270
2014-03-31 $279
2013-12-31 $155
2013-09-30 $166
2013-06-30 $175
2013-03-31 $184
2012-12-31 $196
2012-09-30 $193
2012-06-30 $202
2012-03-31 $210
2011-12-31 $138
2011-09-30 $149
2011-06-30 $127
2011-03-31 $134
2010-12-31 $144
2010-09-30 $150
2010-06-30 $155
2010-03-31 $80
2009-12-31 $71
2009-09-30 $76
2009-06-30 $87
2009-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.876B $2.355B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.625B 33.00
Zoetis (ZTS) United States $74.024B 27.92
Takeda Pharmaceutical (TAK) Japan $44.801B 9.92
Daiichi Sankyo, - (DSNKY) Japan $43.243B 26.35
Sandoz Group AG (SDZNY) Switzerland $20.284B 0.00
Merck (MKKGY) Germany $18.475B 16.55
Astellas Pharma (ALPMY) Japan $17.608B 12.47
United Therapeutics (UTHR) United States $15.992B 15.73
Summit Therapeutics (SMMT) United States $13.894B 0.00
Shionogi (SGIOY) Japan $12.709B 12.73
Orion OYJ (ORINY) Finland $7.630B 21.45
Madrigal Pharmaceuticals (MDGL) United States $7.026B 0.00
Corcept Therapeutics (CORT) United States $6.476B 49.06
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.416B 0.00
Stevanato Group S.p.A (STVN) Italy $6.396B 41.41
Grifols, S.A (GRFS) Spain $5.109B 0.00
Ionis Pharmaceuticals (IONS) United States $5.069B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $3.517B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.211B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.572B 15.37
Catalyst Pharmaceuticals (CPRX) United States $2.535B 11.49
Hypermarcas (HYPMY) Brazil $2.065B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.065B 0.00
Soleno Therapeutics (SLNO) United States $1.941B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.717B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.620B 0.00
Evotec AG (EVO) Germany $1.581B 0.00
Dyne Therapeutics (DYN) United States $1.383B 0.00
Guardian Pharmacy Services (GRDN) United States $1.264B 0.00
Ardelyx (ARDX) United States $1.223B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.153B 0.00
Indivior (INDV) United States $1.138B 4.94
Ocular Therapeutix (OCUL) United States $1.058B 0.00
Xencor (XNCR) United States $1.054B 0.00
ARS Pharmaceuticals (SPRY) United States $1.053B 0.00
Enliven Therapeutics (ELVN) United States $1.043B 0.00
Harrow (HROW) United States $0.982B 0.00
Collegium Pharmaceutical (COLL) United States $0.941B 5.14
Bioventus (BVS) United States $0.814B 25.72
Avadel Pharmaceuticals (AVDL) Ireland $0.795B 0.00
Cronos Group (CRON) Canada $0.734B 0.00
Relay Therapeutics (RLAY) United States $0.649B 0.00
USANA Health Sciences (USNA) United States $0.623B 11.55
Verve Therapeutics (VERV) United States $0.595B 0.00
Xeris Biopharma Holdings (XERS) United States $0.561B 0.00
Elite Pharmaceuticals (ELTP) United States $0.526B 0.00
OmniAb (OABI) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.511B 0.00
Savara (SVRA) United States $0.455B 0.00
CytoDyn (CYDY) United States $0.440B 0.00
ProKidney (PROK) United States $0.437B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.436B 0.00
Altimmune (ALT) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.406B 4.74
Organogenesis (ORGO) United States $0.400B 0.00
Zevra Therapeutics (ZVRA) United States $0.398B 0.00
Aldeyra Therapeutics (ALDX) United States $0.387B 0.00
Akebia Therapeutics (AKBA) United States $0.386B 0.00
Oruka Therapeutics (ORKA) United States $0.380B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.377B 152.79
Esperion Therapeutics (ESPR) United States $0.359B 0.00
Tourmaline Bio (TRML) United States $0.314B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.288B 0.00
Aquestive Therapeutics (AQST) United States $0.270B 0.00
Heron Therapeutics (HRTX) United States $0.269B 0.00
Nature's Sunshine Products (NATR) United States $0.255B 15.19
Avita Medical (RCEL) United States $0.247B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Korro Bio (KRRO) United States $0.239B 0.00
Profound Medical (PROF) Canada $0.224B 0.00
4D Molecular Therapeutics (FDMT) United States $0.209B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.206B 0.00
Lyell Immunopharma (LYEL) United States $0.194B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Larimar Therapeutics (LRMR) United States $0.193B 0.00
Nanobiotix S.A (NBTX) France $0.182B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.178B 0.00
Inhibikase Therapeutics (IKT) United States $0.172B 0.00
Acrivon Therapeutics (ACRV) United States $0.168B 0.00
Nektar Therapeutics (NKTR) United States $0.156B 0.00
Aclaris Therapeutics (ACRS) United States $0.148B 0.00
Silence Therapeutics (SLN) United Kingdom $0.146B 0.00
Inotiv (NOTV) United States $0.137B 0.00
Champions Oncology (CSBR) United States $0.129B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Lexeo Therapeutics (LXEO) United States $0.123B 0.00
Cassava Sciences (SAVA) United States $0.120B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.120B 0.00
ElectroCore (ECOR) United States $0.115B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Journey Medical (DERM) United States $0.112B 0.00
Achieve Life Sciences (ACHV) Canada $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.092B 0.00
Galectin Therapeutics (GALT) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Regulus Therapeutics (RGLS) United States $0.085B 0.00
Nutriband (NTRB) United States $0.084B 0.00
Avalo Therapeutics (AVTX) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Assertio Holdings (ASRT) United States $0.076B 19.92
Karyopharm Therapeutics (KPTI) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Protara Therapeutics (TARA) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.071B 0.00
Fractyl Health (GUTS) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Century Therapeutics (IPSC) United States $0.061B 0.00
AleAnna (ANNA) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
FibroGen (FGEN) United States $0.058B 0.00
OptiNose (OPTN) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
AlloVir (ALVR) United States $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
Rafael Holdings (RFL) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.049B 0.00
Dominari Holdings (DOMH) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
VYNE Therapeutics (VYNE) United States $0.041B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.027B 0.00
BioVie (BIVI) United States $0.027B 0.00
Jupiter Neurosciences (JUNS) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Biomerica (BMRA) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Nuvilex (PMCB) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
China SXT Pharmaceuticals (SXTC) China $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00